Sean P Kennedy, PhD, received his doctorate in microbiology from the University of Massachusetts studying the sequence and genetic structure of Archaea. He then took on a post-doc position at the Massachusetts Institute of Technology (MIT) studying transcription initiation and non-natural amino acids before coming to France in 2005. Sean worked at the CNRS in the domain of cellular division and chromosome replication before taking a position at INRA to head a new NGS sequencing initiative, MetaQuant, studying the intestinal microbiota and its link with obesity. Through his experience in hig-throughput sequencing and data analysis, he served a critical role in the sequence and analysis of metagenomic data for the European projects MetaHIT (obesity, IBS, Crohn’s Disease), EvoTAR (antibiotic resistance in hospitals) and MetaCardis (cardiovascular disease and diabetes) as well as many project with industrial partners involved in allergies and childhood development and disease.
In 2012 the MetaQuant team was a primary founder of the MetaGenoPolis Unit at INRA, financed by the French government’s “Investissements d’Avenir”. By 2015 the platform housed four Life Technologies SOLiD sequencers and a new Life Technologies Ion Proton Sequencer as well as a suite of robotic solutions to fully integrate DNA quantification and NGS library production. Over 100 small to large projects and over 5000 samples were processed during this period.
Sean is now the Director of the Bio-Omics Pole at the Pasteur Institute in Paris. Formerly known as the GenoPole, the Bio-Omics Pole is part of Pasteur’s new Center of Innovation and Technology. In addition to offering high throughput Illumina sequencing of both DNA and RNA samples, and well as chip-based genotyping, the Bio-Omics Pole also include a platform for mass spectrometry.